Reuters logo
BRIEF-Ligand announces licensing agreement with Nucorion Pharmaceuticals
July 29, 2016 / 12:36 PM / a year ago

BRIEF-Ligand announces licensing agreement with Nucorion Pharmaceuticals

July 29 (Reuters) - Ligand Pharmaceuticals Inc :

* Ligand announces multi-program LTP technology licensing agreement with nucorion pharmaceuticals

* Newly-Formed Nucorion, co-founded by Ligand, to pursue a pipeline of LTP-based programs for China and other markets

* Eligible to receive milestone payments as well as royalties ranging from 5% to 9% on net sales of products developed by Nucorion under agreement

* Ligand announces multi-program LTP technology licensing agreement with Nucorion pharmaceuticals Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below